Avi Fischer

Portfolio · 2

XTEND

Human-guided autonomous machine systems for defense, public safety, and security.

1 round $30.0M committed Latest: 2025-07

Optonol

Miniature Surgical Implants for Glaucoma Patients

1 round $10.0M committed Latest: 2000-03

Investment activity

1 portfolio exit on record.

Q&A

What is Avi Fischer's primary investment focus by sector?

Avi Fischer has concentrated investments in the Health Tech & Life Sciences sector, with one portfolio company and one exit in this area.

Can you describe a notable exit for Avi Fischer?

Avi Fischer saw an exit with Optonol, which was acquired by Alcon for $150M in December 2009. Optonol developed miniature surgical implants for glaucoma patients.

What is the typical investment stage for Avi Fischer?

Avi Fischer has participated in Seed stage investments, with one recorded instance.

When was Avi Fischer's most recent recorded investment?

Avi Fischer's most recent recorded investment was in March 2000.

Where is Avi Fischer based?

Avi Fischer is based in Israel.